Kohlberg, Partners-backed PCI Pharma snags Permira’s LSNE at $1.5bn valuation

The PE-backed CDMO grows its mix of work as it gains significant capabilities in lyophilization, an important manufacturing process commonly used in the fast-growing biologics market.